It was also found that the higher expression of CHK1 is closely related to the relapse and drug resistance in tumors [36] and targeting CHK1 with specific inhibitor has been shown pro-apoptotic effect on CD138+ myeloma cells, but not unapparent in CD138- myeloma cells [37]. Here, CHEK1 is linked to plasma cell myeloma.